The angiotensin II receptor antagonist irbesartan for the treatment of portal hypertension: A placebo controlled, double-blind study.

被引：0
|
作者：
Schepke, M [1 ]
Werner, E [1 ]
Bieker, E [1 ]
Schiedermaier, P [1 ]
Hofer, U [1 ]
Layer, G [1 ]
Heller, J [1 ]
Neef, M [1 ]
Sauerbruch, T [1 ]
机构：
[1] Univ Bonn, D-5300 Bonn, Germany
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
985
引用
收藏
页码：406A / 406A
页数：1
相关论文
共 50 条
  • [31] A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges
    Grant, Jon E.
    Kim, Suck Won
    Hartman, Boyd K.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (05) : 783 - 789
  • [32] Epinephrine infusions in panic disorder: A double-blind placebo-controlled study.
    Veltman, DJ
    vanZijderveld, GA
    vanDyck, R
    JOURNAL OF AFFECTIVE DISORDERS, 1996, 39 (02) : 133 - 140
  • [33] Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial
    Kemp, William
    Colman, John
    Thompson, Kenneth
    Madan, Anoop
    Vincent, Margaret
    Chin-Dusting, Jaye
    Kompa, Andrew
    Krum, Henry
    Roberts, Stuart
    LIVER INTERNATIONAL, 2009, 29 (03) : 427 - 433
  • [34] Reduction of arterial stiffness by treatment with the angiotensin receptor antagonist irbesartan in essential hypertension
    Park, JB
    Gang, JY
    Lee, WR
    JOURNAL OF HYPERTENSION, 2004, 22 : S127 - S128
  • [35] Effects of somatostatin on portal pressure during the acute variceal bleeding. A double-blind placebo-controlled study.
    Ortiz, J
    Villanueva, C
    Sabat, M
    Soriano, G
    Vera, JS
    Boadas, J
    Sainz, S
    Torras, J
    Guarner, C
    Balanzo, J
    HEPATOLOGY, 1997, 26 (04) : 25 - 25
  • [36] Efficacy of etanercept (Enbrel®) in the treatment of ankylosing spondylitis:: A randomized, placebo-controlled, double-blind study.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2947 - 2947
  • [37] KETANSERIN IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    CAMERON, HA
    RAMSAY, LE
    POSTGRADUATE MEDICAL JOURNAL, 1985, 61 (717) : 583 - 586
  • [38] A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans
    Cartmell, MT
    O'Reilly, DA
    Porter, C
    Kingsnorth, AN
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2004, 11 (04): : 255 - 259
  • [39] Irbesartan plus propranolol versus propranolol alone in cirrhosis: a placebo-controlled, double-blind study
    Schepke, Michael
    Wiest, Reiner
    Flacke, Sebastian
    Heller, Joerg
    Stoffel-Wagner, Birgit
    Ghauri, Masooma
    Sauerbruch, Tilman
    GASTROENTEROLOGY, 2007, 132 (04) : A801 - A801
  • [40] Valsartan, a new angiotensin II receptor antagonist: A double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide
    Benz, J
    Oshrain, C
    Henry, D
    Avery, C
    Chiang, YT
    Gatlin, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (02): : 101 - 107
12345